[Type 2 diabetes. A new kind of insulin sensitizer at the door].
Böhm
S
S
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D015507:Drugs, Investigational; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077154:Rosiglitazone; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D045162:Thiazolidinediones
D015507:Drugs, Investigational; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077154:Rosiglitazone